spacer gif spacer gif spacer gif spacer gif spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suarez, S.
Right arrow Articles by Ballmer-Hofer, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suarez, S.
Right arrow Articles by Ballmer-Hofer, K.

Journal of Cell Science, Vol 114, Issue 6 1229-1235, Copyright © 2001 by Company of Biologists

JOURNAL ARTICLES

VEGF transiently disrupts gap junctional communication in endothelial cells

S Suarez and K Ballmer-Hofer
Institute of Medical Radiobiology of the University of Zurich and the Paul Scherrer Institute, CH-5232 Villigen, Switzerland.

Vascular endothelial growth factor, VEGF, stimulates angiogenesis by directly acting on endothelial cells. The effects of VEGF are mediated by two tyrosine kinase receptors, VEGFR-1 (Flt-1) and VEGFR-2 (Flk-1/KDR) that are highly related to receptors of the platelet derived growth factor (PDGF) receptor family. We are interested in early signalling events downstream from VEGF receptors that affect blood vessel homeostasis. Endothelial cells form multiple types of cell-cell junctions that are required for cellular organization into complex networks. These junctions also regulate communication among adjacent cells. Stimulation by various growth factors such as epidermal growth factor (EGF) or PDGF has been shown to disrupt cell-cell junctions, consequently affecting cell-to-cell communication. We investigated gap junctional communication (GJC) by monitoring the transfer of a low molecular mass fluorescent tracer molecule between adjacent cells using immunofluorescence microscopy. VEGF maximally blocked GJC 15 minutes after growth factor administration. The cells resumed communication via gap junctions within 1-2 hours after treatment. This early effect of VEGF on communication correlated with changes in the phosphorylation state of one of the proteins involved in gap junction formation, connexin 43 (Cx43). The signalling mechanisms involved in this phenomenon depend on activation of VEGFR-2, impinge on a tyrosine kinase of the Src family and activate the Erk family of MAP kinases. The function of VEGF-mediated disruption of GJC might be to restrict an increase in endothelium permeability to the environment affected by local injury to blood vessels.


This article has been cited by other articles:


Home page
 FASEB J.Home page
S. Cebe-Suarez, F. S. Grunewald, R. Jaussi, X. Li, L. Claesson-Welsh, D. Spillmann, A. A. Mercer, A. E. Prota, and K. Ballmer-Hofer
Orf virus VEGF-E NZ2 promotes paracellular NRP-1/VEGFR-2 coreceptor assembly via the peptide RPPR
FASEB J, August 1, 2008; 22(8): 3078 - 3086.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
F. D. Kolodgie, J. Narula, C. Yuan, A. P. Burke, A. V. Finn, and R. Virmani
Elimination of Neoangiogenesis for Plaque Stabilization: Is There a Role for Local Drug Therapy?
J. Am. Coll. Cardiol., May 29, 2007; 49(21): 2093 - 2101.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
D. Mehta and A. B. Malik
Signaling Mechanisms Regulating Endothelial Permeability
Physiol Rev, January 1, 2006; 86(1): 279 - 367.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Q. Shao, H. Wang, E. McLachlan, G. I.L. Veitch, and D. W. Laird
Down-regulation of Cx43 by Retroviral Delivery of Small Interfering RNA Promotes an Aggressive Breast Cancer Cell Phenotype
Cancer Res., April 1, 2005; 65(7): 2705 - 2711.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
T Yanagawa, T Funasaka, S Tsutsumi, H Watanabe, and A Raz
Novel roles of the autocrine motility factor/phosphoglucose isomerase in tumor malignancy
Endocr. Relat. Cancer, December 1, 2004; 11(4): 749 - 759.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
S. Dhein
Pharmacology of gap junctions in the cardiovascular system
Cardiovasc Res, May 1, 2004; 62(2): 287 - 298.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. J. Haigh, M. Ema, K. Haigh, M. Gertsenstein, P. Greer, J. Rossant, A. Nagy, and E. F. Wagner
Activated Fps/Fes partially rescues the in vivo developmental potential of Flk1-deficient vascular progenitor cells
Blood, February 1, 2004; 103(3): 912 - 920.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
J. C. SAEZ, V. M. BERTHOUD, M. C. BRANES, A. D. MARTINEZ, and E. C. BEYER
Plasma Membrane Channels Formed by Connexins: Their Regulation and Functions
Physiol Rev, October 1, 2003; 83(4): 1359 - 1400.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. U. Naik, S. A. Mousa, C. A. Parkos, and U. P. Naik
Signaling through JAM-1 and {alpha}v{beta}3 is required for the angiogenic action of bFGF: dissociation of the JAM-1 and {alpha}v{beta}3 complex
Blood, September 15, 2003; 102(6): 2108 - 2114.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
A. D. Laird, G. Li, K. G. Moss, R. A. Blake, M. A. Broome, J. M. Cherrington, and D. B. Mendel
Src Family Kinase Activity Is Required for Signal Tranducer and Activator of Transcription 3 and Focal Adhesion Kinase Phosphorylation and Vascular Endothelial Growth Factor Signaling in Vivo and for Anchorage-dependent and -independent Growth of Human Tumor Cells
Mol. Cancer Ther., May 1, 2003; 2(5): 461 - 469.
[Abstract] [Full Text] [PDF]


© The Company of Biologists Ltd 2001